- Approval by shareholders of all the resolutions proposed at the General Meeting and approved by the Board of Directors
The General Meeting of Eramet Shareholders was held on Wednesday, May 27th, 2026 in Paris, chaired by Ms. Christel Bories, Chair and CEO of the Group. Shareholders voted in favour of all resolutions recommended by the Board of Directors.
At the Extraordinary General Meeting, the shareholders notably approved the delegation of authority to the Board of Directors to increase the share capital to strengthen its equity. This capital increase will be carried out through the issuance of ordinary shares, while maintaining pre-emptive subscription rights for existing shareholders, for a maximum amount of €500 million. It is planned for H2 2026.
At the Ordinary General Meeting, the shareholders notably ratified the co-optation as Director, effective from today, of Ms. Murielle Minkoué Mézui, which occurred during the Board Meeting of March 19th, 2026, to replace Mr. Tanguy Gahouma-Békalé, who has resigned, for the remaining term of his man date, i.e. until the General Meeting called to approve the financial statements for fiscal year 2028.
Following the Shareholders’ General Meeting, Eramet’s Board of Directors consists of 18 members, including two employee representatives. It comprises 7 independent members and 8 women, repre senting respectively 44% and 50% of the Board members, excluding employee representatives. De tailed information on the composition of the Board of Directors and its Committees is available on the Company’s website under the Governance section: Eramet governance.
The voting results for each resolution are available on Eramet’s website (Shareholders’ General Meeting 2026).
In line with the announcement made in February alongside the publication of the Group’s full-year results1, no dividend will be paid for the financial year 2025.
1- Press release of February 18th, 2026
